{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:27:19Z","timestamp":1794446839349,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    COVID-19 was declared a pandemic on March 11 by WHO, due to its great threat to global public health. The coronavirus main protease (M\n                    <jats:sup>pro<\/jats:sup>\n                    , also called 3CLpro) is essential for processing and maturation of the viral polyprotein, therefore recognized as an attractive drug target. Here we show that a clinically approved anti-HCV drug, Boceprevir, and a pre-clinical inhibitor against feline infectious peritonitis (corona) virus (FIPV), GC376, both efficaciously inhibit SARS-CoV-2 in Vero cells by targeting M\n                    <jats:sup>pro<\/jats:sup>\n                    . Moreover, combined application of GC376 with Remdesivir, a nucleotide analogue that inhibits viral RNA dependent RNA polymerase (RdRp), results in sterilizing additive effect. Further structural analysis reveals binding of both inhibitors to the catalytically active side of SARS-CoV-2 protease M\n                    <jats:sup>pro<\/jats:sup>\n                    as main mechanism of inhibition. Our findings may provide critical information for the optimization and design of more potent inhibitors against the emerging SARS-CoV-2 virus.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-18233-x","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T06:03:02Z","timestamp":1599199382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":522,"title":["Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-5424","authenticated-orcid":false,"given":"Lifeng","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qisheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihua","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-0370","authenticated-orcid":false,"given":"Hao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3053-2687","authenticated-orcid":false,"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8903-9793","authenticated-orcid":false,"given":"Xuebing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-1136","authenticated-orcid":false,"given":"Wenjie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-615X","authenticated-orcid":false,"given":"George Fu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"18233_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang, C., Horby, P. W., Hayden, F. G. & Gao, G. F. A novel coronavirus outbreak of global health concern. Lancet 395, 470\u2013473 (2020).","journal-title":"Lancet"},{"key":"18233_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.46234\/ccdcw2020.017","volume":"2","author":"W Tan","year":"2020","unstructured":"Tan, W. et al. A novel coronavirus genome identified in a cluster of pneumonia cases \u2014 Wuhan, China 2019\u22122020. China CDC Weekly 2, 61\u201362 (2020).","journal-title":"China CDC Weekly"},{"key":"18233_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","volume":"382","author":"Q Li","year":"2020","unstructured":"Li, Q. et al. Early transmission dynamics in wuhan, china, of novel coronavirus-infected pneumonia. New Engl. J. Med. 382, 1199\u20131207 (2020).","journal-title":"New Engl. J. Med."},{"key":"18233_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"18233_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A Novel Coronavirus from patients with pneumonia in China, 2019. New Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"New Engl. J. Med."},{"key":"18233_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1056\/NEJMc2001272","volume":"382","author":"LT Phan","year":"2020","unstructured":"Phan, L. T. et al. Importation and human-to-human transmission of a novel coronavirus in Vietnam. New Engl. J. Med. 382, 872\u2013874 (2020).","journal-title":"New Engl. J. Med."},{"key":"18233_CR7","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","volume":"382","author":"ML Holshue","year":"2020","unstructured":"Holshue, M. L. et al. First Case of 2019 Novel coronavirus in the United States. New Engl. J. Med. 382, 929\u2013936 (2020).","journal-title":"New Engl. J. Med"},{"key":"18233_CR8","unstructured":"WHO. WHO Director-General\u2019s opening remarks at the media briefing on COVID-19 - 11 March 2020, https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020 (2020)."},{"key":"18233_CR9","unstructured":"WHO. World Health Organization: Coronavirus disease (COVID-2019) situation reports, https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports (2020)."},{"key":"18233_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(20)30419-0","volume":"395","author":"S Jiang","year":"2020","unstructured":"Jiang, S. et al. A distinct name is needed for the new coronavirus. Lancet 395, 949 (2020).","journal-title":"Lancet"},{"key":"18233_CR11","doi-asserted-by":"crossref","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536\u2013544 (2020).","DOI":"10.1038\/s41564-020-0695-z"},{"key":"18233_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565\u2013574 (2020).","journal-title":"Lancet"},{"key":"18233_CR13","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W-j Guan","year":"2020","unstructured":"Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"New Engl. J. Med."},{"key":"18233_CR14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054\u20131062 (2020).","journal-title":"Lancet"},{"key":"18233_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292.e6 (2020).","journal-title":"Cell"},{"key":"18233_CR16","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"18233_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"18233_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181, 894\u2013904.e9 (2020).","journal-title":"Cell"},{"key":"18233_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5582\/ddt.2020.01012","volume":"14","author":"L Dong","year":"2020","unstructured":"Dong, L., Hu, S. & Gao, J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov. Ther. 14, 58\u201360 (2020).","journal-title":"Drug Discov. Ther."},{"key":"18233_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269\u2013271 (2020).","journal-title":"Cell Res."},{"key":"18233_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5582\/bst.2020.01020","volume":"14","author":"H Lu","year":"2020","unstructured":"Lu, H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci. Trends 14, 69\u201371 (2020).","journal-title":"Biosci. Trends"},{"key":"18233_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s11684-020-0757-x","volume":"14","author":"L Ni","year":"2020","unstructured":"Ni, L., Zhou, L., Zhou, M., Zhao, J. & Wang, D. W. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19. Front. Med. 14, 210\u2013214 (2020).","journal-title":"Front. Med."},{"key":"18233_CR23","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/med.21475","volume":"38","author":"AA Agbowuro","year":"2018","unstructured":"Agbowuro, A. A., Huston, W. M., Gamble, A. B. & Tyndall, J. D. A. Proteases and protease inhibitors in infectious diseases. Med. Res. Rev. 38, 1295\u20131331 (2018).","journal-title":"Med. Res. Rev."},{"key":"18233_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao, B. et al. A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19. New Engl. J. Med. 382, 1787\u20131799 (2020).","journal-title":"New Engl. J. Med."},{"key":"18233_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jmb.2006.11.073","volume":"366","author":"X Xue","year":"2007","unstructured":"Xue, X. et al. Production of authentic SARS-CoV Mpro with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction. J. Mol. Biol. 366, 965\u2013975 (2007).","journal-title":"J. Mol. Biol."},{"key":"18233_CR26","doi-asserted-by":"crossref","unstructured":"Jin, Z. et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","DOI":"10.1038\/s41586-020-2223-y"},{"key":"18233_CR27","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1021\/jm060173k","volume":"50","author":"AJ Prongay","year":"2007","unstructured":"Prongay, A. J. et al. Discovery of the HCV NS3\/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization. J. Med. Chem. 50, 2310\u20132318 (2007).","journal-title":"J. Med. Chem."},{"key":"18233_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1128\/AAC.50.3.1013-1020.2006","volume":"50","author":"BA Malcolm","year":"2006","unstructured":"Malcolm, B. A. et al. SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells. Antimicrob. Agents Chemother. 50, 1013\u20131020 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"18233_CR29","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1128\/JVI.01348-12","volume":"86","author":"Y Kim","year":"2012","unstructured":"Kim, Y. et al. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J. Virol. 86, 11754\u201311762 (2012).","journal-title":"J. Virol."},{"key":"18233_CR30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1098612X17729626","volume":"20","author":"NC Pedersen","year":"2018","unstructured":"Pedersen, N. C. et al. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J. Feline Med. Surg. 20, 378\u2013392 (2018).","journal-title":"J. Feline Med. Surg."},{"key":"18233_CR31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science 368, 409\u2013412 (2020).","journal-title":"Science"},{"key":"18233_CR32","doi-asserted-by":"crossref","unstructured":"Dai, W. et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368, 1331\u20131335 (2020).","DOI":"10.1126\/science.abb4489"},{"key":"18233_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152606776056706","volume":"6","author":"C Lin","year":"2006","unstructured":"Lin, C., Kwong, A. D. & Perni, R. B. Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease. Infect. Disord. Drug Targets 6, 3\u201316 (2006).","journal-title":"Infect. Disord. Drug Targets"},{"key":"18233_CR34","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1002\/anie.200906696","volume":"49","author":"MD Cummings","year":"2010","unstructured":"Cummings, M. D. et al. Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3\/NS4A protease target. Angew. Chem. Int. Ed. 49, 1652\u20131655 (2010).","journal-title":"Angew. Chem. Int. Ed."},{"key":"18233_CR35","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1021\/cb5006118","volume":"9","author":"DI Soumana","year":"2014","unstructured":"Soumana, D. I., Ali, A. & Schiffer, C. A. Structural analysis of asunaprevir resistance in HCV NS3\/4A protease. ACS Chem. Biol. 9, 2485\u20132490 (2014).","journal-title":"ACS Chem. Biol."},{"key":"18233_CR36","doi-asserted-by":"publisher","first-page":"e1002832","DOI":"10.1371\/journal.ppat.1002832","volume":"8","author":"KP Romano","year":"2012","unstructured":"Romano, K. P. et al. The molecular basis of drug resistance against hepatitis C virus NS3\/4A protease inhibitors. PLoS Pathog. 8, e1002832 (2012).","journal-title":"PLoS Pathog."},{"key":"18233_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1098612X17729626","volume":"20","author":"NC Pedersen","year":"2017","unstructured":"Pedersen, N. C. et al. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J. Feline Med. Surg. 20, 378\u2013392 (2017).","journal-title":"J. Feline Med. Surg."},{"key":"18233_CR38","doi-asserted-by":"publisher","first-page":"e1005531","DOI":"10.1371\/journal.ppat.1005531","volume":"12","author":"Y Kim","year":"2016","unstructured":"Kim, Y. et al. Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor. PLoS Pathog. 12, e1005531 (2016).","journal-title":"PLoS Pathog."},{"key":"18233_CR39","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","volume":"3","author":"H Yang","year":"2005","unstructured":"Yang, H. et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 3, e324 (2005).","journal-title":"PLoS Biol."},{"key":"18233_CR40","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.1073\/pnas.1835675100","volume":"100","author":"H Yang","year":"2003","unstructured":"Yang, H. et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl Acad. Sci. USA 100, 13190\u201313195 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"18233_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"18233_CR42","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1107\/S0907444901012471","volume":"57","author":"RJ Read","year":"2001","unstructured":"Read, R. J. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr. D Biol. Crystallogr. 57, 1373\u20131382 (2001).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"18233_CR43","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"18233_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"18233_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18233-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18233-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18233-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T19:32:16Z","timestamp":1670268736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18233-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18233"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18233-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"23 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4417"}}